These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 23827121)

  • 21. Successful bortezomib-based treatment in POEMS syndrome.
    Tang X; Shi X; Sun A; Qiu H; Gu B; Zhou H; Xue S; Liu Y; Ruan C; Wu D
    Eur J Haematol; 2009 Dec; 83(6):609-10. PubMed ID: 19674063
    [No Abstract]   [Full Text] [Related]  

  • 22. Improvement of zoledronic-acid-induced jaw osteonecrosis with bortezomib.
    Timurağaoğlu A; Ozkaynak C; Tuzuner S; Bostan F; Undar L
    Acta Haematol; 2007; 118(4):203-4. PubMed ID: 17992010
    [No Abstract]   [Full Text] [Related]  

  • 23. Autologous peripheral blood stem cell transplantation and the role of lenalidomide in patients affected by poems syndrome.
    Autore F; Innocenti I; Luigetti M; Piccirillo N; Sora F; Chiusolo P; Sica S; Bacigalupo A; Laurenti L
    Hematol Oncol; 2018 Apr; 36(2):392-398. PubMed ID: 28913957
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Bortezomib plus dexamethasone treatment followed by reduced-intensity allogeneic stem cell transplantation for multiple myeloma refractory to high-dose chemotherapy with autologous transplantation].
    Hayashi T; Yasui H; Kawakami K; Ikeda H; Takahashi F; Kobayashi T; Nishimura S; Ishida T; Imai K; Shinomura Y
    Rinsho Ketsueki; 2011 Mar; 52(3):136-41. PubMed ID: 21471701
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sequential vincristine, adriamycin, dexamethasone (VAD) followed by bortezomib, thalidomide, dexamethasone (VTD) as induction, followed by high-dose therapy with autologous stem cell transplant and consolidation therapy with bortezomib for newly diagnosed multiple myeloma: results of a phase II trial.
    Kim HJ; Yoon SS; Lee DS; Sohn SK; Eom HS; Lee JL; Chung JS; Kim K; Suh C; Won JH; Kim JS; Park JS; Kang HJ; Seong CM; Kim CS; Lee SJ; Lee JH
    Ann Hematol; 2012 Feb; 91(2):249-56. PubMed ID: 21789621
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [POEMS syndrome presenting with transient immunoglobulin isotype switching after successful treatment with autologous peripheral blood stem cell transplantation].
    Nakamura Y; Sato Y; Ito Y; Maeda T; Takahashi N; Kawai N; Jinnai I; Bessho M; Kinoshita S; Yamamoto T
    Rinsho Ketsueki; 2007 Aug; 48(8):642-6. PubMed ID: 17867301
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stem cell collection in patients with de novo multiple myeloma treated with the combination of bortezomib and dexamethasone before autologous stem cell transplantation according to IFM 2005-01 trial.
    Moreau P; Hulin C; Marit G; Caillot D; Facon T; Lenain P; Berthou C; Pégourié B; Stoppa AM; Casassus P; Michallet M; Benboubker L; Maisonneuve H; Doyen C; Leyvraz S; Mathiot C; Avet-Loiseau H; Attal M; Harousseau JL;
    Leukemia; 2010 Jun; 24(6):1233-5. PubMed ID: 20428201
    [No Abstract]   [Full Text] [Related]  

  • 28. [Effect of bortezomib-based induction therapy on the peripheral blood stem cell harvest in multiple myeloma].
    Muta T; Miyamoto T; Fujisaki T; Ohno Y; Kamimura T; Henzan T; Kato K; Takenaka K; Iwasaki H; Eto T; Takamatsu Y; Teshima T; Akashi K;
    Rinsho Ketsueki; 2013 Jan; 54(1):109-16. PubMed ID: 23391654
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neurologic improvement after peripheral blood stem cell transplantation in POEMS syndrome.
    Kuwabara S; Misawa S; Kanai K; Suzuki Y; Kikkawa Y; Sawai S; Hattori T; Nishimura M; Nakaseko C
    Neurology; 2008 Nov; 71(21):1691-5. PubMed ID: 18832140
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Peripheral blood stem cell transplantation for POEMS syndrome.
    Peggs KS; Paneesha S; Kottaridis PD; Chakraverty RK; Tobias G; Reilly M; Mahendra P; Yong K
    Bone Marrow Transplant; 2002 Sep; 30(6):401-4. PubMed ID: 12235526
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term durable efficacy of autologous stem cell transplantation in POEMS syndrome.
    Saini NY; Patel RD; Varma A; Bashir Q; Delgado R; Rondon G; Popat U; Hosing C; Nieto Y; Kebriaei P; Weber DM; Thomas SK; Lee HC; Manasanch EE; Orlowski RZ; Champlin RE; Qazilbash MH; Patel KK
    Am J Hematol; 2019 Mar; 94(3):E72-E74. PubMed ID: 30548467
    [No Abstract]   [Full Text] [Related]  

  • 32. Bortezomib and dexamethasone as first-line therapy for a patient with newly diagnosed polyneuropathy, organomegaly, endocrinopathy, M protein and skin changes syndrome complicated by renal failure.
    Li J; Zhang W; Kang WY; Cao XX; Duan MH; Zhou DB
    Leuk Lymphoma; 2012 Dec; 53(12):2527-9. PubMed ID: 22553961
    [No Abstract]   [Full Text] [Related]  

  • 33. Cytomegalovirus reactivation following autologous peripheral blood stem cell transplantation for multiple myeloma in the era of novel chemotherapeutics and tandem transplantation.
    Kim JH; Goulston C; Sanders S; Lampas M; Zangari M; Tricot G; Hanson KE
    Biol Blood Marrow Transplant; 2012 Nov; 18(11):1753-8. PubMed ID: 22728249
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Spontaneous autologous graft-versus-host disease in plasma cell myeloma autograft recipients: flow cytometric analysis of hematopoietic progenitor cell grafts.
    Lazarus HM; Sommers SR; Arfons LM; Fu P; Ataergin SA; Kaye NM; Liu F; Kindwall-Keller TL; Cooper BW; Laughlin MJ; Creger RJ; Barr PM; Gerson SL; Kaplan D
    Biol Blood Marrow Transplant; 2011 Jul; 17(7):970-8. PubMed ID: 21440080
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New developments in the treatment of patients with multiple myeloma.
    Minnema MC; van der Spek E; van de Donk NW; Lokhorst HM
    Neth J Med; 2010 Jan; 68(1):24-32. PubMed ID: 20103818
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bortezomib/dexamethasone followed by autologous stem cell transplantation as front line treatment for light-chain deposition disease.
    Tovar N; Cibeira MT; Rosiñol L; Solé M; de Larrea CF; Escoda L; Rovira M; Bladé J
    Eur J Haematol; 2012 Oct; 89(4):340-4. PubMed ID: 22690902
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of lenalidomide plus dexamethasone for POEMS syndrome relapsed after autologous peripheral stem-cell transplantation.
    Vannata B; Laurenti L; Chiusolo P; Sorà F; Balducci M; Sabatelli M; Luigetti M; Giannotta C; De Stefano V; Leone G; Sica S
    Am J Hematol; 2012 Jun; 87(6):641-2. PubMed ID: 22488443
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Autologous peripheral blood stem cell transplantation for POEMS syndrome.
    Kuwabara S; Misawa S; Kanai K; Kikkawa Y; Nishimura M; Nakaseko C; Cho RK; Hattori T
    Neurology; 2006 Jan; 66(1):105-7. PubMed ID: 16401856
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Successful hematopoietic stem-cell transplantation in multicentric Castleman disease complicated by POEMS syndrome.
    Ganti AK; Pipinos I; Culcea E; Armitage JO; Tarantolo S
    Am J Hematol; 2005 Jul; 79(3):206-10. PubMed ID: 15981232
    [TBL] [Abstract][Full Text] [Related]  

  • 40. "Short course" bortezomib plus melphalan and prednisone as induction prior to transplant or as frontline therapy for nontransplant candidates in patients with previously untreated multiple myeloma.
    Gasparetto C; Gockerman JP; Diehl LF; de Castro CM; Moore JO; Long GD; Horwitz ME; Keogh G; Chute JP; Sullivan KM; Neuwirth R; Davis PH; Sutton LM; Anderson RD; Chao NJ; Rizzieri D
    Biol Blood Marrow Transplant; 2010 Jan; 16(1):70-7. PubMed ID: 19733251
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.